HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was -29.41K shares.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 35.15K shares.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 3.95K shares, a 97.73% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 3.90K shares, a 90.16% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 13.59K shares, a 93.64% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 213.64K shares, a 430.57% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 40.27K shares, a 93.06% decline from fiscal 2021.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 579.97K shares, a 128.47% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | -29.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 13.59K shares 10-K · filed 2026-03-13 |
| 2024-09-30 | 35.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 43.00K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 3.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 7.85K shares derived: sum of 4 quarters · filed 2025-03-14 |
| 2024-03-31 | 3.90K shares 10-Q · filed 2024-05-07 | 177.93K shares derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 213.64K shares 10-K · filed 2025-03-14 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 213.64K shares derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-06-30 | 174.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 238.31K shares derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-03-31 | 39.62K shares 10-Q · filed 2023-04-26 | 68.90K shares derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 40.27K shares 10-K · filed 2024-03-07 |
| 2022-09-30 | 24.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 85.37K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-06-30 | 4.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 98.77K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-03-31 | 10.99K shares 10-Q · filed 2022-05-04 | 280.79K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | 45.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 579.97K shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 38.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | 778.72K shares derived: sum of 4 quarters · filed 2022-03-11 |
| 2021-06-30 | 186.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | 743.29K shares derived: sum of 4 quarters · filed 2022-03-11 |
| 2021-03-31 | 310.17K shares 10-Q · filed 2021-05-07 | |
| 2020-12-31 | 243.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 253.85K shares 10-K · filed 2022-03-11 |
| 2020-09-30 | 2.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2019-12-31 | 1.25K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | 3.75K shares 10-K/A · filed 2021-03-17 |
| 2019-09-30 | -500.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -1.68M shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-06-30 | 500.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -712.25K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | 2.50K shares 10-Q · filed 2019-05-08 | -291.75K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | -1.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 3.75K shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 971.00K shares 10-Q · filed 2019-11-08 | 3.46M shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | 421.00K shares 10-Q · filed 2019-08-08 | 2.42M shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | 298.00K shares 10-Q · filed 2019-05-08 | 2.00M shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | 1.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 1.70M shares 10-K · filed 2020-03-16 |
| 2017-09-30 | -70.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 673.86K shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 707.82K shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | -5.71K shares 10-Q · filed 2017-05-08 | |
| 2016-12-31 | 749.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 375.00K shares 10-K · filed 2018-03-16 |
| 2016-09-30 | -36.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | |
| 2015-12-31 | 1.77M shares 10-K · filed 2018-03-16 | |
| 2014-12-31 | 695.00K shares 10-K · filed 2017-03-17 | |
| 2013-12-31 | 4.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | 2.13M shares 10-K · filed 2016-04-29 |
| 2013-09-30 | -1.39M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -1.15M shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | -87.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 210.03K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | -447.53K shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 771.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 648.00K shares 10-K · filed 2015-03-12 |
| 2012-09-30 | -25.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | |
| 2011-12-31 | 106.00K shares 10-K · filed 2014-03-14 | |
| 2010-12-31 | 58.38K shares 10-K · filed 2013-03-18 | |
| 2009-12-31 | 123.00K shares 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |